Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma

BACKGROUND: Classical patient and tumour characteristics are the benchmark of personalised breast cancer (BC) management. Recent evidence has demonstrated that immune and molecular profiling of BC may also play an important role. Despite evidence of differences between invasive ductal (IDC) and lobu...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Engels, C C, Fontein, D B Y, Kuppen, P J K, de Kruijf, E M, Smit, V T H B M, Nortier, J W R, Liefers, G J, van de Velde, C J H, Bastiaannet, E
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2014
Témata:
Molecular Diagnostics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4119991/
https://ncbi.nlm.nih.gov/pubmed/24937677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.338
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky